Biotron Ltd BIT
Trading Information
- Previous Close Price
- A$0.00
- Day Range
- A$0.00–0.00
- 52-Week Range
- A$0.00–0.01
- Bid/Ask
- A$0.00 / A$0.00
- Shares Outstanding
- 2.79B
- Market Cap
- A$5.57M
- Volume/Avg
- 10,000 / 5M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Biotron Ltd is an Australian biotechnology company focused on the development and commercialization of antiviral therapies and neuroscience-related products. The company reports two operating segments: SedRx, focused on anesthetic and neuroscience products, and Viron, which encompasses antiviral drug development programs. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 4
- Website
- https://www.biotron.com.au
Valuation
|
Metric
|
BIT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.85 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BIT
|
|---|---|
Quick Ratio | 1.92 |
Current Ratio | 1.94 |
Interest Coverage | — |
Quick Ratio
BIT
Profitability
|
Metric
|
BIT
|
|---|---|
Return on Assets (Normalized) | −53.09% |
Return on Equity (Normalized) | −73.80% |
Return on Invested Capital (Normalized) | −75.64% |
Return on Assets
BIT
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|CvM$KD! | LOCK|l%%%p | $129B | |||
| Moderna Inc
MRNA
| LOCK|!^d&t# | LOCK|#X% | $85B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|H@^>Cs | LOCK|zHcd | $79B | |||
| argenx SE ADR
ARGX
| LOCK|!%SCg%c | LOCK|v% | $52B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|PX<swyB | LOCK|%!F | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|N<zgkY | LOCK|pmZ^ | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|jFYZx&>$ | LOCK|k!>&w | $26B | |||
| BioNTech SE ADR
BNTX
| LOCK|!^v&Gh | LOCK|<B? | $24B | |||
| Incyte Corp
INCY
| LOCK|Z<kK!J | LOCK|$Yb | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|Q&h<!#^ | LOCK|^W | $14B |
United States